Yes, I much prefer a company to use cash flow to invest in their business rather than go to the market with cap in hand or go into too much debt.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025